Related Experiment Video
Updated: Feb 15, 2026
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Comparison of Homocysteine, Zinc, and Copper Levels in Patients with Chronic Obstructive Pulmonary Disease and
1Department of Pulmonary Diseases, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkiye.
Objective:
To compare serum homocysteine, zinc, and copper levels between chronic obstructive pulmonary disease (COPD) patients and healthy controls, and to assess their associations with systemic inflammation.
Study Design:
A comparative cross-sectional study. Place and Duration of the Study: Department of Pulmonary Diseases, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkiye, from February to April 2025.
Methodology:
This study evaluated homocysteine, folic acid, vitamin B12, zinc, and copper levels in 30 COPD patients and 30 healthy controls (HCs). Pearson's chi-square test was used to compare categorical variables between groups. The Student's t-test was employed for comparisons between two groups. Pearson's correlation analysis was conducted to assess the relationship between continuous variables.
Results:
Statistically significant differences were found in leucocyte, platelet, red cell distribution width (RDW), immature granulocyte, and immature granulocyte percentage levels in COPD patients (p <0.001, p = 0.024, p = 0.002, p = 0.035, and p = 0.022, respectively). CRP levels were significantly elevated in the COPD group (p = 0.006). No statistically significant differences were found in homocysteine, folic acid, vitamin B12, zinc, and copper levels between the COPD and Control groups (p >0.05). All measured values in both groups were within the normal reference ranges. However, zinc levels positively correlated with RDW (r = 0.417; p = 0.030), and a negative correlation was observed between copper levels and RDW (r = -0.543; p = 0.009) in the COPD group.
Conclusion:
Homocysteine, zinc, copper, vitamin B12, and folic acid levels did not differ between COPD patients and HCs, all within normal ranges. Secondary analyses showed significant haematogram and CRP alterations, indicating systemic inflammation. These markers cannot be used as inflammatory parameters in COPD.
Key Words:
COPD, Homocysteine, Zinc, Copper, Vitamin B12, Folic acid.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: